CTI Acquires Mirada Solutions
|
By HospiMedica staff writers Posted on 12 Sep 2003 |
In a move to enhance the company's positron emission tomography (PET) systems, CTI Molecular Imaging, Inc. (Knoxville, TN, USA) has acquired Mirada Solutions Limited (Oxford, UK). Terms were not disclosed.
Mirada, a spinoff from Oxford University, is a developer of fusion software applications for medical imaging workstations. CTI plans to incorporate Mirada's image analysis and fusion software into all its PET scanner workstations, to enhance the analytical and diagnostic capabilities of its PET systems. Mirada has developed several products designed to provide better detection, diagnosis, and disease management through the application of image analysis software to medical images.
"We believe that we have acquired the best-in-class capability that will further distinguish our PET scanners in the marketplace,” said Terry Douglas, chairman and CEO of CTI. "With this acquisition, we not only offer the fastest scan time through our proprietary LSO technology, but we also provide the greatest level of PET image functionality for the clinician.”
Related Links:
CTI
Mirada
Mirada, a spinoff from Oxford University, is a developer of fusion software applications for medical imaging workstations. CTI plans to incorporate Mirada's image analysis and fusion software into all its PET scanner workstations, to enhance the analytical and diagnostic capabilities of its PET systems. Mirada has developed several products designed to provide better detection, diagnosis, and disease management through the application of image analysis software to medical images.
"We believe that we have acquired the best-in-class capability that will further distinguish our PET scanners in the marketplace,” said Terry Douglas, chairman and CEO of CTI. "With this acquisition, we not only offer the fastest scan time through our proprietary LSO technology, but we also provide the greatest level of PET image functionality for the clinician.”
Related Links:
CTI
Mirada
Latest Business News
- Medtronic to Acquire Coronary Artery Medtech Company CathWorks
- Medtronic and Mindray Expand Strategic Partnership to Ambulatory Surgery Centers in the U.S.
- FDA Clearance Expands Robotic Options for Minimally Invasive Heart Surgery
- WHX in Dubai (formerly Arab Health) to debut specialised Biotech & Life Sciences Zone as sector growth accelerates globally
- WHX in Dubai (formerly Arab Health) to bring together key UAE government entities during the groundbreaking 2026 edition
- Interoperability Push Fuels Surge in Healthcare IT Market
- Philips and Masimo Partner to Advance Patient Monitoring Measurement Technologies
- B. Braun Acquires Digital Microsurgery Company True Digital Surgery
- CMEF 2025 to Promote Holistic and High-Quality Development of Medical and Health Industry
- Bayer and Broad Institute Extend Research Collaboration to Develop New Cardiovascular Therapies
- Medtronic Partners with Corsano to Expand Acute Care & Monitoring Portfolio in Europe
- Expanded Collaboration to Transform OR Technology Through AI and Automation
- Becton Dickinson to Spin Out Biosciences and Diagnostic Solutions Business
- Boston Scientific Acquires Medical Device Company SoniVie
- 2026 World Hospital Congress to be Held in Seoul
- Teleflex to Acquire BIOTRONIK’s Vascular Intervention Business
Channels
Artificial Intelligence
view channelCritical Care
view channel
Intranasal Spray to Prevent Illnesses from Respiratory Viruses
Respiratory viruses such as influenza and COVID-19 hospitalize more than one million people in the U.S. each year, with many infections spreading through close contact in households, schools, and workplaces.... Read more
AI Risk Prediction Tool Improves Treatment of Cancer Patients after Heart Attack
Cancer patients who experience a heart attack face a uniquely dangerous combination of risks, including higher chances of death, bleeding, and repeat cardiac events. Because of this complexity, they have... Read moreSurgical Techniques
view channel
Surgical Innovation Cuts Ovarian Cancer Risk by 80%
Ovarian cancer remains the deadliest gynecological cancer, largely because there is no reliable screening test, and most cases are diagnosed at advanced stages. Thousands of patients die each year as treatment... Read more
New Imaging Combo Offers Hope for High-Risk Heart Patients
Patients with type 2 diabetes often develop complex, severe coronary artery disease involving multiple narrowed or blocked arteries, making complete revascularization difficult. Without detailed functional... Read morePatient Care
view channel
Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care
More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more
VR Training Tool Combats Contamination of Portable Medical Equipment
Healthcare-associated infections (HAIs) impact one in every 31 patients, cause nearly 100,000 deaths each year, and cost USD 28.4 billion in direct medical expenses. Notably, up to 75% of these infections... Read more
Portable Biosensor Platform to Reduce Hospital-Acquired Infections
Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read moreFirst-Of-Its-Kind Portable Germicidal Light Technology Disinfects High-Touch Clinical Surfaces in Seconds
Reducing healthcare-acquired infections (HAIs) remains a pressing issue within global healthcare systems. In the United States alone, 1.7 million patients contract HAIs annually, leading to approximately... Read moreHealth IT
view channel
EMR-Based Tool Predicts Graft Failure After Kidney Transplant
Kidney transplantation offers patients with end-stage kidney disease longer survival and better quality of life than dialysis, yet graft failure remains a major challenge. Although a successful transplant... Read more







